See All Slides - tctmd.com

Slides

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

Presentation TCTAP 2013

Can We Prevent Conduction Disturbances?

Presenter: Corrado Tamburino

April 25, 2013

Presentation TCTAP 2013

Clinical Outcomes after Transcatheter Aortic Valve Replacement (TAVR) Using Valve Academic Research Consortium (VARC) Definitions: A Weighted Meta-Analysis of 3,519 Patients from 16 Studies

Presenter: Philippe Généreux

April 25, 2013

Presentation TCTAP 2013

Lessons from European Registries

Presenter: Alain Cribier

April 25, 2013

Presentation TCTAP 2013

How to Choose TAVI or SAVR

Presenter: I. Sheiban

April 25, 2013

Presentation TCTAP 2013

TAVI Technology and Procedural Changes

Presenter: Eberhard Grube

April 25, 2013

Presentation

Platelet Responsiveness to Clopidogrel Treatment After Peripheral Endovascular Procedures

Presenter: Stavros Spiliopoulos

April 25, 2013

Presentation TCTAP 2013

Can We Afford TAVR? Economic Insights from the PARTNER Trial

Presenter: David J. Cohen

April 25, 2013

Presentation TCTAP 2013

ESSENCE-DIABETES II Trial

Presenter: Gyung-Min Park

April 25, 2013

Presentation TCTAP 2013

Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-Eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry

Presenter: Jung-Min Ahn

April 25, 2013

Advertisement

Slides

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Can We Prevent Conduction Disturbances?

Clinical Outcomes after Transcatheter Aortic Valve Replacement (TAVR) Using Valve Academic Research Consortium (VARC) Definitions: A Weighted Meta-Analysis of 3,519 Patients from 16 Studies

Lessons from European Registries

How to Choose TAVI or SAVR

TAVI Technology and Procedural Changes

Platelet Responsiveness to Clopidogrel Treatment After Peripheral Endovascular Procedures

Can We Afford TAVR? Economic Insights from the PARTNER Trial

ESSENCE-DIABETES II Trial

Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-Eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content